NICE guidance on type 2 diabetes management (NG28) outlines numerous alternative agents, including other GLP-1 receptor agonists, SGLT2 inhibitors, or DPP-4 inhibitors, depending on individual patient factors and treatment goals
1 Weight loss in LEGACY also reduced left atrial size, blood pressure, and the burden of AF episodes on monitoring
Key Takeaways GLP-1 medications reduce food noise by dampening dopamine-driven cravings, helping separate true hunger from impulse-driven eating, and creating more control around food choices
It is also possible that GLP-1RAs may have a therapeutic effect across traditional diagnostic categories
If youre taking Ozempic (semaglutide), you probably already know it can change the way your body handles food and drinks